Mesoblast Ltd
ASX:MSB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Mesoblast Ltd
ASX:MSB
|
AU |
|
A
|
After You Public Co Ltd
SET:AU
|
TH |
|
S
|
Saha-Union PCL
SET:SUC
|
TH |
|
Burgundy Diamond Mines Ltd
ASX:BDM
|
AU |
Intrinsic Value
Is MSB undervalued or overvalued?
See the intrinsic value estimate for Mesoblast Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
MSB looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with MSB’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Mesoblast Does
Mesoblast is a biotechnology company that develops cell-based medicines, especially treatments made from donated adult stem cells. Its main work is to research, test, and seek approval for therapies aimed at hard-to-treat inflammatory and immune-related diseases, as well as some serious spine and heart conditions.
- Headquarters
- Australia AU
- Employees
- 81
- IPO date
- Dec 16, 2004
Mesoblast has a narrow economic moat
Mesoblast Ltd has a narrow economic moat, offering limited protection against competitors and some ability to sustain profitability.
Read the full moat analysis
Revenue & Expenses Breakdown
Mesoblast Ltd
Earnings Waterfall
Mesoblast Ltd
The intrinsic value for Mesoblast Ltd (MSB) under the Base Case is hidden AUD.
Compared with the current market price of 1.99 AUD, the stock appears hidden.